Literature DB >> 5075509

Effect of cell size on lipolysis and antilipolytic action of insulin in human fat cells.

B Jacobsson, U Smith.   

Abstract

The lipolytic response to catecholamines and the antilipolytic effect of $$Word$$ were studied as a function of adipose cell size and number. The results show that cellular enlargement is associated with an increase in the basal lipolysis as well as the release of glycerol induced by salbutamol (a beta(2)-receptor agonist), noradrenaline, adrenaline, and isopropyl-noradrenaline. The glycerol release induced by all these agents seems to be more favorably correlated with cell surface area than with cell volume or diameter. Under the incubation conditions used with glucose in the medium, the antilipolytic effect of insulin on the basal as well as on the adrenaline- and isopropylnoradrenaline-stimulated lipolysis was not consistent at any cell size studied. However, in the presence of noradrenaline and salbutamol, insulin exerted a consistent antilipolytic effect. The results show that the larger adipose cells are at least as sensitive to the antilipolytic effect of insulin as the smaller cells. The results imply that the previously reported diminished responsiveness to insulin shown by large adipose cells is exerted only on the side of lipid accumulation. It is suggested that the negative correlation between cell size and responsiveness to insulin on the side of lipid accumulation may be one way to control adipose cell enlargement.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5075509

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  26 in total

1.  Single-cell analysis of insulin-regulated fatty acid uptake in adipocytes.

Authors:  Oleg Varlamov; Romel Somwar; Anda Cornea; Paul Kievit; Kevin L Grove; Charles T Roberts
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-06-22       Impact factor: 4.310

2.  Lipolysis defect in white adipose tissue and rapid weight regain.

Authors:  Michal Kasher-Meron; Dou Y Youn; Haihong Zong; Jeffery E Pessin
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-04-09       Impact factor: 4.310

3.  Influence of cell size on the effects of insulin and noradrenaline on human adipose tissue.

Authors:  B Jacobsson; G Holm; P Björntorp; U Smith
Journal:  Diabetologia       Date:  1976-03       Impact factor: 10.122

4.  Cell size and the antilipolytic effect of insulin in human subcutaneous adipose tissue.

Authors:  J Ostman; L Backman; D Hallberg
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

5.  Cellular basis of insulin insensitivity in large rat adipocytes.

Authors:  M P Czech
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

6.  Studies of human adipose tissue in culture. 3. Influence of insulin and medium glucose concentration on cellular metabolism.

Authors:  U Smith
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

Review 7.  Role of body fat distribution and the metabolic complications of obesity.

Authors:  Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

8.  The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity.

Authors:  Jean O'Connell; Lydia Lynch; Tom J Cawood; Anna Kwasnik; Niamh Nolan; Justin Geoghegan; Aiden McCormick; Cliona O'Farrelly; Donal O'Shea
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

9.  Antilipolytic effect of calcium-sensing receptor in human adipocytes.

Authors:  Mariana Cifuentes; Cecilia V Rojas
Journal:  Mol Cell Biochem       Date:  2008-07-13       Impact factor: 3.396

10.  Lipoprotein lipase but not hormone-sensitive lipase activities achieve normality after surgically induced weight loss in morbidly obese patients.

Authors:  E Pardina; A Lecube; R Llamas; R Catalán; R Galard; J M Fort; H Allende; V Vargas; J A Baena-Fustegueras; J Peinado-Onsurbe
Journal:  Obes Surg       Date:  2009-05-20       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.